Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › WI › Milwaukee › NPI 1053343442
Lab

Ascension Wisconsin Laboratories, INC

Ascension Wisconsin Laboratories, INC was paid $5.81M by Medicaid between Jan 2018 and Dec 2024, across 146 billing codes. Its largest line is 87491, Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe — 8.4% of everything it billed.

33Billing provider infoASCENSION WISCONSIN LABORATORIES, INC
MILWAUKEE, WI 53211
33aNPI1053343442assigned 07/07/2006
33bProvider typeClinical Medical Laboratory
28Total paid$5.81M
24GClaims482,227
24DCodes billed146
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Clinical Medical Laboratory providers in Wisconsin

Rank by total paid#13 of 75
Median peer was paid$106K
This provider vs. median55×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official MCCULLOUGH, MICHAEL controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$50K$100K$150K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201880,849$1.26M
201977,288$1.06M
202075,430$1.04M
202193,122$822K
2022102,687$1.18M
202345,017$431K
2024incomplete7,834$12K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 8.4% 16,067 14,616 $489K
80050 General health panel 8.3% 13,106 10,793 $484K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 8.0% 16,040 14,596 $467K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 7.2% 14,208 12,768 $417K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 5.1% 13,890 12,444 $297K
80061 Lipid panel 4.9% 27,882 25,199 $287K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 4.9% 4,483 3,683 $283K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 3.8% 9,868 8,947 $219K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 3.3% 4,664 4,163 $193K
80053 Comprehensive metabolic panel 3.3% 25,060 22,418 $192K
84443 Thyroid stimulating hormone (TSH) 3.1% 16,320 14,606 $182K
83036 Hemoglobin; glycosylated (A1C) 2.8% 22,624 20,515 $161K
134 more codes
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 2.7% 5,444 $156K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 2.2% 6,721 $131K
82607 2.0% 9,237 $117K
86481 1.7% 1,432 $101K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.6% 19,501 $95K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1.5% 2,315 $87K
86780 1.1% 8,207 $65K
86803 1.1% 5,533 $64K
80048 Basic metabolic panel (calcium, ionized) 1.1% 9,961 $64K
87653 <1% 1,730 $58K
85027 <1% 11,229 $57K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 2,873 $56K
87086 Culture, bacterial; quantitative colony count, urine <1% 8,547 $56K
84153 <1% 3,526 $53K
82728 <1% 4,789 $49K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 651 $48K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 3,015 $40K
84439 <1% 5,247 $38K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 157 $38K
82746 <1% 2,750 $34K
83550 <1% 4,946 $33K
80081 <1% 648 $33K
82043 <1% 6,672 $30K
86703 <1% 1,859 $29K
81025 <1% 3,768 $28K
83540 <1% 5,292 $26K
87340 <1% 2,949 $24K
82570 <1% 5,750 $24K
87070 <1% 2,848 $22K
87081 <1% 3,594 $22K
81001 <1% 8,117 $21K
86480 <1% 367 $20K
84702 <1% 1,778 $20K
87186 <1% 2,420 $17K
81003 <1% 8,764 $17K
86762 <1% 1,353 $16K
84403 <1% 742 $16K
83970 <1% 576 $14K
86140 <1% 3,183 $14K
85610 <1% 4,007 $13K
87210 <1% 3,455 $13K
84146 <1% 746 $12K
83001 <1% 813 $12K
U0001 Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel <1% 413 $11K
86235 <1% 962 $10K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 325 $10K
87077 <1% 1,516 $10K
80500 <1% 859 $9K
83655 <1% 1,019 $9K
82950 <1% 2,011 $9K
86787 <1% 1,113 $8K
82550 <1% 1,337 $7K
80055 <1% 567 $7K
36415 Collection of venous blood by venipuncture <1% 70,272 $7K
85651 <1% 2,130 $7K
86850 <1% 1,808 $7K
81420 Fetal chromosomal aneuploidy genomic sequence analysis panel <1% 15 $7K
80076 <1% 1,077 $7K
84550 <1% 1,908 $7K
87147 <1% 1,442 $6K
83735 <1% 1,086 $6K
86706 <1% 680 $6K
86038 <1% 639 $5K
84481 <1% 408 $5K
87088 <1% 703 $5K
83516 <1% 469 $5K
87634 <1% 94 $5K
84460 <1% 1,110 $5K
86431 <1% 932 $5K
80074 <1% 169 $5K
87252 <1% 119 $4K
Q0111 Wet mounts, including preparations of vaginal, cervical or skin specimens <1% 697 $3K
99001 <1% 1,008 $3K
83880 <1% 119 $3K
83690 <1% 571 $3K
84480 <1% 248 $3K
85652 <1% 1,369 $3K
86900 <1% 1,254 $3K
86901 <1% 1,207 $3K
86039 <1% 392 $3K
84165 <1% 288 $3K
86225 <1% 251 $2K
84450 <1% 551 $2K
82962 <1% 836 $2K
83721 <1% 352 $2K
83020 <1% 403 $2K
86003 <1% 34 $2K
86200 <1% 194 $2K
86704 <1% 193 $2K
87075 <1% 213 $2K
83615 <1% 343 $2K
83002 <1% 115 $1K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 82 $1K
86765 <1% 93 $1K
82565 <1% 370 $1K
87205 <1% 336 $1K
82784 <1% 114 $1K
85007 <1% 418 $1K
84156 <1% 346 $944.30
86160 <1% 149 $929.76
82670 <1% 44 $887.10
82947 <1% 247 $753.57
85018 <1% 364 $714.02
84402 <1% 32 $664.50
82785 <1% 39 $541.69
84270 <1% 30 $523.47
85730 <1% 142 $467.39
85014 <1% 241 $439.87
Q0112 All potassium hydroxide (koh) preparations <1% 78 $374.43
82465 <1% 79 $371.72
88141 <1% 32 $366.19
85379 <1% 44 $331.37
86376 <1% 31 $329.20
84100 <1% 89 $227.52
84703 <1% 32 $192.40
84520 <1% 70 $181.81
87338 <1% 14 $162.93
87110 <1% 12 $161.73
88142 <1% 15 $128.25
86255 <1% 15 $116.03
86769 <1% 16 $96.33
88304 <1% 16 $87.93
85613 <1% 13 $67.06
85045 <1% 12 $58.10
84155 <1% 25 $54.72
85732 <1% 17 $51.76
87140 <1% 12 $51.54
99000 <1% 14 $35.64
81015 <1% 71 $30.52
P9603 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled <1% 14 $5.13
80361 0% 267 $0.00
80365 0% 489 $0.00
P9604 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge 0% 136 $0.00
80354 0% 22 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMCCULLOUGH, MICHAEL (CFO)
Same official

Other billing entities under MCCULLOUGH, MICHAEL

Full network →
ProviderLocationPaid
Ascension Se Wisconsin Hospital, INCMilwaukee, WI$94.32M
Columbia ST. Mary's Hospital Milwaukee, INC.Milwaukee, WI$64.53M
Ascension ST Francis Hospital, INCMilwaukee, WI$35.87M
Ascension Ne Wisconsin, INCAppleton, WI$19.89M
A.F.C. Transportation, INCFlagstaff, AZ$10.12M
Columbia ST. Mary's Hospital Milwaukee, INCMilwaukee, WI$9.82M
Ascension Ne Wisconsin, INCOshkosh, WI$4.31M
Ascension Via Christi Hospitals Wichita INC.Wichita, KS$4.09M
Ascension Calumet Hospital, INCChilton, WI$3.78M
Columbia ST. Mary's Hospital Milwaukee INCMilwaukee, WI$769K
Sacred Heart Rehabilitation Institute, INC.Mequon, WI$603K
Mercy Medical Center of Oshkosh, INC.Oshkosh, WI$486K
Ascension Ne Wisconsin, INCAppleton, WI$343K
Columbia ST. Mary's Hospital Milwaukee, INCGlendale, WI$158K
Columbia ST. Mary's Hospital Milwaukee, INCMilwaukee, WI$140K
Ascension Ne Wisconsin, INCMenasha, WI$63K
Columbia ST. Mary's Hospital Milwaukee, INCMequon, WI$26K
Ascension Se Wisconsin Hospital, INCWauwatosa, WI$9K
Sacred Heart Rehabilitation Institute, INCMilwaukee, WI$6K
Ascension Wisconsin Surgery Center-Mount Pleasant LLCMount Pleasant, WI$5K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.